1.Graham A, Heath P, Morten JE, Markham AF (March 1991). The human aldose reductase gene maps to chromosome region 7q35. Human Genetics. 86 (5): 509–14. doi:10.1007/BF00194644. PMID 1901827. S2CID 34446965.
2.Grewal AS, Bhardwaj S, Pandita D, Lather V, Sekhon BS (2016-01-01). Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases. Mini Reviews in Medicinal Chemistry. 16 (2): 120–62. doi:10.2174/1389557515666150909143737. PMID 26349493.
3.O'connor T, Ireland LS, Harrison DJ, Hayes JD (October 1999). Major differences exist in the function and tissue- specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. The Biochemical Journal. 343 Pt 2 (2): 487 – 504. doi:10.1042/bj3430487. PMC 1220579. PMID 10510318.
4.Lefrançois-Martinez AM, Bertherat J, Val P, Tournaire C, Gallo-Payet N, Hyndman D, Veyssière G, Bertagna X, Jean C, Martinez A (June 2004). Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors. The Journal of Clinical Endocrinology and Metabolism. 89 (6): 3010–9. doi:10.1210/jc.2003-031830. PMID 15181092.